CEL-SCI CORPORATION (CVM) Current Ratio
- Current ratio · latest quarter: Value 1.48×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.48× | Current assets / current liabilities. $7.50M ÷ $5.08M ≈ 1.48× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 7.50M USD | Assets, Current |
| Current obligations | 5.08M USD | Liabilities, Current |
| Cash and equivalents | (m) | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | Inventory, Net |
| Payables | 1.02M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.50M | $5.08M | (m) | (m) | (m) | (m) | $1.02M | (m) | 1.48× |
| 2026-03-31 | $2.89M | $4.81M | (m) | (m) | (m) | (m) | $933.79K | (m) | 0.60× |
| 2025-12-31 | $7.03M | $5.04M | (m) | (m) | (m) | (m) | $1.03M | (m) | 1.39× |
| 2025-09-30 | $11.60M | $5.13M | (m) | (m) | (m) | (m) | $1.06M | (m) | 2.26× |
| 2025-06-30 | $2.62M | $5.62M | (m) | (m) | (m) | (m) | $1.58M | (m) | 0.47× |
| 2025-03-31 | $3.02M | $5.50M | (m) | (m) | (m) | (m) | $1.70M | (m) | 0.55× |
| 2024-12-31 | $5.86M | $5.48M | (m) | (m) | (m) | (m) | $2.00M | (m) | 1.07× |
| 2024-09-30 | $6.06M | $4.62M | (m) | (m) | (m) | (m) | $1.45M | (m) | 1.31× |
| 2024-06-30 | $3.54M | $5.51M | (m) | (m) | (m) | (m) | $1.37M | (m) | 0.64× |
| 2024-03-31 | $8.51M | $5.09M | (m) | (m) | (m) | (m) | $1.02M | (m) | 1.67× |
| 2023-12-31 | $6.15M | $4.87M | (m) | (m) | (m) | $2.35M | $1.14M | (m) | 1.26× |
| 2023-09-30 | $6.92M | $5.59M | (m) | (m) | (m) | $2.25M | $2.01M | (m) | 1.24× |
| 2023-06-30 | $7.73M | $5.29M | $5.14M | (m) | (m) | (m) | $1.74M | (m) | 1.46× |
| 2023-03-31 | $12.57M | $5.31M | $10.05M | (m) | (m) | (m) | $1.89M | (m) | 2.37× |
| 2022-12-31 | $20.40M | $4.74M | $18.02M | (m) | (m) | (m) | $1.60M | (m) | 4.30× |
| 2022-09-30 | $25.44M | $4.66M | (m) | (m) | (m) | $2.00M | $1.62M | (m) | 5.45× |
| 2022-06-30 | $30.96M | $4.02M | $28.07M | (m) | $0.00 | (m) | $852.86K | (m) | 7.71× |
| 2022-03-31 | $37.28M | $4.47M | $34.28M | (m) | $0.00 | (m) | $1.32M | (m) | 8.33× |
| 2021-12-31 | $41.87M | $3.33M | $37.11M | (m) | $54.92K | (m) | $1.19M | (m) | 12.56× |
| 2021-09-30 | $45.27M | $3.94M | $36.06M | (m) | $54.92K | $2.01M | $1.68M | (m) | 11.50× |
| 2021-06-30 | $49.73M | $5.16M | $35.96M | (m) | $54.92K | $1.58M | $2.14M | (m) | 9.64× |
| 2021-03-31 | $19.87M | $5.82M | $6.43M | (m) | $54.92K | $1.46M | $2.39M | (m) | 3.41× |
| 2020-12-31 | $23.70M | $7.33M | $21.86M | (m) | $54.92K | $1.15M | $3.09M | (m) | 3.23× |
| 2020-09-30 | $17.70M | $4.27M | $15.51M | (m) | $54.92K | $820.05K | $2.02M | (m) | 4.15× |
| 2020-06-30 | $22.68M | $4.65M | $20.14M | (m) | $255.01K | $787.01K | $943.82K | (m) | 4.88× |
| 2020-03-31 | $15.81M | $5.27M | $14.33M | (m) | $62.29K | $849.55K | $1.14M | (m) | 3.00× |
| 2019-12-31 | $10.75M | $4.57M | $9.38M | (m) | $91.04K | $905.88K | $1.44M | (m) | 2.35× |
| 2019-09-30 | $9.81M | $3.02M | $8.44M | (m) | $62.77K | $782.36K | $1.59M | (m) | 3.25× |
| 2019-06-30 | $10.59M | $4.23M | $9.49M | (m) | $118.26K | $754.83K | $2.08M | (m) | 2.51× |
| 2019-03-31 | $6.75M | $5.47M | $5.51M | (m) | $123.24K | $761.01K | $4.16M | (m) | 1.23× |
| 2018-12-31 | $7.93M | $5.89M | $6.68M | (m) | $128.76K | $682.52K | $4.90M | (m) | 1.35× |
| 2018-09-30 | $11.44M | $9.23M | $10.31M | (m) | $118.66K | $645.24K | $5.74M | (m) | 1.24× |
| 2018-06-30 | $3.44M | $8.38M | $2.35M | (m) | $119.65K | $628.16K | $6.25M | (m) | 0.41× |
| 2018-03-31 | $4.71M | $10.86M | $3.06M | (m) | $136.78K | $630.31K | $7.69M | (m) | 0.43× |
| 2017-12-31 | $3.64M | $10.60M | $2.14M | (m) | $47.61K | $644.75K | $7.87M | (m) | 0.34× |
| 2017-09-30 | $4.24M | $10.84M | $2.37M | (m) | $218.48K | $672.52K | $8.20M | (m) | 0.39× |
| 2017-06-30 | $2.98M | $10.24M | $1.23M | (m) | $271.74K | $657.74K | $8.35M | (m) | 0.29× |
| 2017-03-31 | $3.08M | $8.41M | $1.53M | (m) | $4.25K | $678.66K | $7.07M | (m) | 0.37× |
| 2016-12-31 | $4.11M | $3.79M | $2.39M | (m) | $4.13K | $694.50K | $2.74M | (m) | 1.08× |
| 2016-09-30 | $5.46M | $4.01M | $2.92M | (m) | $394.51K | $1.01M | $3.09M | (m) | 1.36× |
| 2016-06-30 | $8.58M | $5.28M | $5.22M | (m) | $790.66K | $1.26M | $4.44M | (m) | 1.62× |
| 2016-03-31 | $9.43M | $5.09M | $6.05M | (m) | $654.83K | $1.30M | $3.77M | (m) | 1.85× |
| 2015-12-31 | $13.70M | $5.68M | $10.42M | (m) | $378.27K | $1.34M | $3.86M | (m) | 2.41× |
| 2015-09-30 | $8.35M | $6.71M | $5.73M | (m) | $87.21K | $1.40M | $5.13M | (m) | 1.24× |
| 2015-06-30 | $14.67M | $5.27M | $11.23M | (m) | $158.49K | $1.42M | $3.16M | (m) | 2.78× |
| 2015-03-31 | $5.70M | $3.68M | $2.61M | (m) | $37.43K | $1.57M | $1.70M | (m) | 1.55× |
| 2014-12-31 | $12.31M | $3.79M | $9.46M | (m) | $155.94K | $1.24M | $1.64M | (m) | 3.25× |
| 2014-09-30 | $11.65M | $3.15M | $8.51M | (m) | $81.82K | $1.45M | $1.16M | (m) | 3.69× |
| 2014-06-30 | $17.35M | $3.33M | $14.29M | (m) | $80.44K | $1.41M | $1.36M | (m) | 5.22× |
| 2014-03-31 | $13.85M | $3.32M | $10.61M | (m) | $134.95K | $1.42M | $1.35M | (m) | 4.17× |
| 2013-12-31 | $16.61M | $3.38M | $13.49M | (m) | $45.88K | $1.35M | $1.63M | (m) | 4.92× |
| 2013-09-30 | $2.51M | $3.55M | $41.61K | (m) | $74.26K | $1.02M | $1.92M | (m) | 0.71× |
| 2013-06-30 | $6.24M | $2.97M | $3.48M | (m) | $163.74K | $1.14M | $1.18M | (m) | 2.10× |
| 2013-03-31 | $10.21M | $1.88M | $6.99M | (m) | $39.56K | $1.29M | $465.82K | (m) | 5.43× |
| 2012-12-31 | $13.60M | $1.78M | $10.74M | (m) | $14.90K | $1.14M | $410.25K | (m) | 7.63× |
| 2012-09-30 | $7.44M | $1.91M | $3.94M | (m) | $158.61K | $1.38M | $592.87K | (m) | 3.89× |
| 2012-06-30 | $11.05M | $2.03M | $7.22M | (m) | $25.65K | $1.37M | $702.69K | (m) | 5.45× |
| 2012-03-31 | $9.28M | $2.03M | $5.27M | (m) | $101.46K | $1.37M | $708.09K | (m) | 4.58× |
| 2011-12-31 | $7.32M | $4.95M | $3.46M | (m) | $8.63K | $1.37M | $631.92K | (m) | 1.48× |
| 2011-09-30 | $9.02M | $7.22M | $4.26M | (m) | $457.34K | $1.57M | $738.95K | (m) | 1.25× |
| 2011-06-30 | $15.57M | $11.02M | $10.58M | (m) | $414.13K | $1.58M | $1.27M | (m) | 1.41× |
| 2010-09-30 | $29.09M | $3.30M | $26.57M | (m) | $0.00 | $1.48M | $1.50M | (m) | 8.83× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |